Immunology, molecular biology and control of flaviviruses (Dengue and Zika)
Immunology, molecular biology and control of flaviviruses (Dengue and Zika)
批准号:
1923696
负责人:
金额:
$0.0万
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The flaviviruses Dengue and Zika are endemic to much of the tropical and sub-tropical areas of the world. Spread by Aedes mosquitos, one estimate indicates 390 million dengue infections per year, of which 96 million manifest clinically (with any severity of disease). Another study, of the prevalence of dengue, estimates that 3.9 billion people, in 128 countries, are at risk of infection with dengue viruses. Although Zika virus was first identified in the 1950s it was an outbreak in 2015 in South America which brought it to global attention, during this outbreak there was a marked increase in cases of children born with birth defects. The efficiency of Dengue disease transmission can be seen in places such as Singapore, where very low numbers of these mosquitos can be found (Aedes premises index of less than 1% and virtually no infected mosquitos identified) and yet incidence rates are high (typically more than 200 cases notified per year per 100,000 residents) and in 2013 there were more than 23,000 hospitalizations (for a population of 5.5 million).Despite Dengue virus being one of the most studied viruses, some critical components of the epidemiology dynamics are unknown. For example; the mosquito typically only flies 150m in its life time of two weeks (and two feeding periods) and dengue infected patients are typically only contagious to the mosquito for 3 to 6 days (during the fever stage). Extensive recent research has concentrated on explaining mosquito numbers in relation to weather variables and correlating this to disease incidence, but further work integrating this knowledge with viral molecular epidemiology is likely to reveal more precise details of how the disease spreads from person to person.Next-generation sequencing technologies can allow phylogenetic analysis of viral outbreaks, can reveal the path of the outbreak and additionally can detect mutations that may be associated with new disease phenotypes or affect molecular diagnostics. These can be used to therefore infer transmission dynamics. This project will utilize a comprehensively monitored cohort from Vietnam to follow real time dengue outbreaks, household clusters of cases and obtain blood samples that will permit molecular typing, together with serological data. Taken together, this data will enable mathematical model testing and refinement; while also initiating a field site that could later be used for interventions.I will initially be focussing on developing and using molecular detection techniques to diagnose and sequence the virus. Data generated by this will then be used to infer routes of transmission as well as how the virus responds to immunological pressures.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
-
批准号:82370981
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:陈敏洁
-
依托单位:
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
-
批准号:82372073
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张淼
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
OBSL1功能缺失导致多指(趾)畸形的分子机制及其临床诊断价值
-
批准号:82372328
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:项盈
-
依托单位:
O6-methyl-dGTP抑制胶质母细胞瘤的作用及分子机制研究
-
批准号:82304565
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:李瑾
-
依托单位:
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
-
批准号:82371704
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:徐步芳
-
依托单位:
Irisin通过整合素调控黄河鲤肌纤维发育的分子机制研究
-
批准号:32303019
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:职韶阳
-
依托单位:
上皮细胞黏着结构半桥粒在热激保护中的作用机制研究
-
批准号:31900545
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:傅容
-
依托单位: